Clinical value of prostatic specific antigen level in serum of the lesions of prostate gland and its importance as a screening test and tumour marker for carcinoma of prostate gland correlated with histopathology

Journal Title: International Journal of Medical and Health Research - Year 2017, Vol 3, Issue 8

Abstract

Prostate Cancer is the leading cancer in older men. when detected early (organ confined ), it is potentially curable by radical prostatectomy. Therefore, early detection is important and PSA is widely used for this purpose. It is considered one of the most promising tumour markers available PSA is an extremely useful tumour marker and is used to detect and monitor treatment of prostate cancer. Prior to introduction of testing for prostate specific antigen(PSA), two-thirds of prostate cancers were discovered after they were incurable. By this test, physicians / surgeons can now catch most prostate cancers before they spread beyond the prostate. PSA is produced by the prostate, a male sex gland about the size of a walnut that makes the fluid that carries sperms. Raised level of PSA normally is not found in a blood. In men with prostate disease, however, PSA levels in the blood may rise; two leading causes are: benign prostatic hyperplasia (BPH) and prostate cancer. PSA levels under 4 ng/ml are considered normal whereas above 10 ng/ml are cause for biopsy. In the “ diagnostic gray zone “, its levels between 4 and 10 ng/ml, the free PSA test can help differentiate between cancer and benign conditions such as BPH. PSA exists in multiple forms in the blood. Most of it remains bound to proteins, but some is free floating. In the early 1990 s, it was discovered that measuring the ratio of “ free to total “ PSA could further help in distinguishing prostate cancer from benign prostate disease.

Authors and Affiliations

Dr. Mrinal Kanti Mallik, Dr. Najma Khan, Dr. Ananya Mallik

Keywords

Related Articles

Assessment of prevalence and clinical outcome of the acute encephalitis syndrome in children’s at DMCH

The purpose of AES surveillance is to estimate disease burden, to understand disease pattern, and its influence on mortality and morbidity. Surveillance helps in documenting the burden of the disease and also helps in pr...

Comparative study of safety and efficacy of glucosamine in patients of osteoarthritis

Osteoarthritis is an age related problem which decline in the synthesis of Glucosamine in our body. Due to the reduction in the glucosamine sulphate concentration at joint cartilage ground substance Chondroitin sulphate...

Original research article: Electrocardiographic changes in patients with stroke

Background: Stroke, also known as cerebrovascular accident (CVA), is the 3rd most common cause of death worldwide, after ischemic heart disease and cancer. Stroke is defined as damage to the brain due to interruption of...

Assessment of malarial fever in children by estimation of haematological profile

Haematological changes are very commonly associated with malaria and play a significant role in serious complications associated with the disease. The haematological abnormalities that have been reported to consistently...

Significance of Beta 2-Microglobulin to predict the development of HIV/AIDS

Background: Beta 2-Microglobulin (β2M) is a component of the Class I major histocompatibility molecule which is present on the surface of almost all nucleated host cells. An increase in β2M serum levels has been associat...

Download PDF file
  • EP ID EP586636
  • DOI -
  • Views 121
  • Downloads 0

How To Cite

Dr. Mrinal Kanti Mallik, Dr. Najma Khan, Dr. Ananya Mallik (2017). Clinical value of prostatic specific antigen level in serum of the lesions of prostate gland and its importance as a screening test and tumour marker for carcinoma of prostate gland correlated with histopathology. International Journal of Medical and Health Research, 3(8), 48-51. https://europub.co.uk/articles/-A-586636